APA (7th ed.) Citation

RK, V., NN, M., & CL, R. (2021). ASO Author Reflections: Imatinib Use Remains Inadequate for High-Risk GIST Patients. Annals of surgical oncology, 28(13), 9169. https://doi.org/10.1245/s10434-021-10162-3

Chicago Style (17th ed.) Citation

RK, Voss, Massarweh NN, and Roland CL. "ASO Author Reflections: Imatinib Use Remains Inadequate for High-Risk GIST Patients." Annals of Surgical Oncology 28, no. 13 (2021): 9169. https://doi.org/10.1245/s10434-021-10162-3.

MLA (9th ed.) Citation

RK, Voss, et al. "ASO Author Reflections: Imatinib Use Remains Inadequate for High-Risk GIST Patients." Annals of Surgical Oncology, vol. 28, no. 13, 2021, p. 9169, https://doi.org/10.1245/s10434-021-10162-3.